ctrl K

Price Alert

Fate Therapeutics Inc. (FATE)

NASDAQ: FATE · Real-Time Price · USD

1.09

0.02 (1.87%)

At close: Aug 15, 2025, 3:59 PM

1.14

4.11%

After-hours: Aug 15, 2025, 07:57 PM EDT

Fate Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.06M	41.87M	61.33M	133.58M
Short-Term Investments	243.01M	273.31M	374.89M	482.33M
Long-Term Investments	27.66M	980K	4.94M	100.66M
Other Long-Term Assets	10.24M	15.19M	132.48M	116.66M
Receivables	3.54M	1.83M	38.48M	8.68M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	9.3M	14.54M	27.37M	n/a
Total Current Assets	291.91M	331.54M	502.07M	633.41M
Property-Plant & Equipment	110.89M	158.51M	66.07M	70.72M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	148.78M	174.68M	203.49M	288.04M
Total Assets	440.69M	506.22M	705.56M	921.46M
Account Payables	9.37M	4.72M	8.27M	8.61M
Deferred Revenue	393K	685K	42.23M	21.48M
Short-Term Debt	7.42M	6.18M	5.63M	5.58M
Other Current Liabilities	4.22M	10.78M	34.41M	21.68M
Total Current Liabilities	38.52M	39.09M	114.05M	81.28M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	5.6M	1.35M	3.86M	24.97M
Total Long-Term Liabilities	83.45M	98.71M	107.57M	161.33M
Total Liabilities	121.97M	137.8M	221.62M	242.62M
Total Debt	85.27M	103.54M	109.34M	114.82M
Common Stock	114K	99K	97K	96K
Retained Earnings	-1.4B	-1.21B	-1.05B	-769.08M
Comprehensive Income	268K	15K	-1.85M	-762K
Shareholders Equity	318.73M	368.42M	483.94M	678.84M
Total Investments	270.67M	274.29M	379.84M	582.99M